4//SEC Filing
Suzdak Peter David 4
Accession 0001140361-18-003900
CIK 0001228627other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:39 PM ET
Size
5.2 KB
Accession
0001140361-18-003900
Insider Transaction Report
Form 4
Suzdak Peter David
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2018-01-26+112,271→ 112,271 totalExercise: $2.29Exp: 2028-01-26→ Common Stock (112,271 underlying)
Footnotes (1)
- [F1]One quarter of the option vests and becomes exercisable on January 26, 2019, and, thereafter, 1/36th of the remaining option vests in equal installments on the first business day of each month until fully vested.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001296629
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:39 PM ET
- Size
- 5.2 KB